# Eyedeal

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/eyedeal

- Industry: Medical Devices & Equipment
- Headquarters: Xi'an, China
- Website: www.eyedeal.com
- Total disclosed funding: $15M
- Latest round: Series B (Apr 23, 2023)
- Investors on record: 3

## About

Established in 2015 and based in Xi'an, China, Eyedeal is a research and development manufacturer of ophthalmic medical devices. In 2015, Mr. Guangxu Guo, the founder of the company, purchased the material invention patent of Dr. Len Pinchuk, a member of the National Academy of Engineering, and founded the company. The CTO, Zhou Yang, worked at Alcon. The company has established scientific research platforms such as Shaanxi Provincial Engineering Technology Research Center and Postdoctoral Innovation Base. In 2021, Eyedeal's IOL received CE marketing license in EU. In April 2023, Eyedeal raised closed a round of CNY 100 million series B funding.

The company mainly produces medical equipment products such as IOLs for the treatment of eye diseases, including IOLs, keratoplasty lenses, crystalline eye IOLs, glaucoma shadow flow tubes and polymer medical materials. Among them, the company has developed a unique cross-linked polyolefin IOL, which was approved as a key project of the National Key Research and Development Program, and the hydrophobic acrylate aspheric IOL was approved for marketing by the State Drug Administration.

## Funding rounds

- Series B, Apr 23, 2023, $15M — PAG, YuanBio Venture, Zhong Ou AMC

## Investors

- PAG (https://capitalatlas.ai/funds/pag) — Series B
- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series B
- Zhong Ou AMC — Series B